Literature DB >> 1642754

Intermolecular cooperativity: a clue to why mice have IgG3?

N S Greenspan1, L J Cooper.   

Abstract

Mouse IgG3 subclass antibodies predominate in humoral responses to bacterial polysaccharide antigens. The reasons for this isotype restriction are not fully understood. Here, Neil Greenspan and Laurence Cooper propose that intermolecular cooperativity, a novel mechanism of antibody binding, may help to explain the preferential expression of IgG3 antibodies in these responses.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1642754     DOI: 10.1016/0167-5699(92)90120-V

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  28 in total

1.  CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies.

Authors:  R S Chu; T McCool; N S Greenspan; J R Schreiber; C V Harding
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Human constant regions influence the antibody binding characteristics of mouse-human chimeric IgG subclasses.

Authors:  N McCloskey; M W Turner; P Steffner; R Owens; D Goldblatt
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

3.  Carbohydrate-monophosphoryl lipid a conjugates are fully synthetic self-adjuvanting cancer vaccines eliciting robust immune responses in the mouse.

Authors:  Qianli Wang; Zhifang Zhou; Shouchu Tang; Zhongwu Guo
Journal:  ACS Chem Biol       Date:  2011-11-01       Impact factor: 5.100

4.  Integrin β1 Promotes the Interaction of Murine IgG3 with Effector Cells.

Authors:  Carolyn Saylor Hawk; Carolina Coelho; Diane Sthefany Lima de Oliveira; Verenice Paredes; Patrícia Albuquerque; Anamélia Lorenzetti Bocca; Ananésia Correa Dos Santos; Victoria Rusakova; Heather Holemon; Ildinete Silva-Pereira; Maria Sueli Soares Felipe; Hideo Yagita; André Moraes Nicola; Arturo Casadevall
Journal:  J Immunol       Date:  2019-03-20       Impact factor: 5.422

5.  Immunogenicity of protein therapeutics: The key causes, consequences and challenges.

Authors:  Matthew P Baker; Helen M Reynolds; Brooke Lumicisi; Christine J Bryson
Journal:  Self Nonself       Date:  2010-10

6.  Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1.

Authors:  O Scharf; H Golding; L R King; N Eller; D Frazier; B Golding; D E Scott
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  IgG subclass co-expression brings harmony to the quartet model of murine IgG function.

Authors:  Andrew M Collins
Journal:  Immunol Cell Biol       Date:  2016-08-09       Impact factor: 5.126

Review 8.  Cooperative binding by mouse IgG3 antibodies: implications for functional affinity, effector function, and isotype restriction.

Authors:  N S Greenspan; L J Cooper
Journal:  Springer Semin Immunopathol       Date:  1993

9.  IgG2 subclass restriction of anti-beta 2 glycoprotein 1 antibodies in autoimmune patients.

Authors:  J Arvieux; B Roussel; D Ponard; M G Colomb
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

10.  Murine IgG1 and IgG3 isotype switch variants promote phagocytosis of Cryptococcus neoformans through different receptors.

Authors:  Carolyn A Saylor; Ekaterina Dadachova; Arturo Casadevall
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.